share_log

Vertical Research Downgrades RXO to Hold, Announces $23 Price Target

Benzinga ·  Jan 10 10:37

Vertical Research analyst Jeffrey Kauffman downgrades RXO (NYSE:RXO) from Buy to Hold and announces $23 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment